Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy

References

Page 1

	Year	Citations
Two-Photon Laser Scanning Fluorescence Microscopy Winfried Denk, James H. Strickler, Watt W. Webb Science	1990	9.3K
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse Dale Schenk, Robin Barbour, Whitney Dunn, Nature Neurodegenerative DiseasesAlzheimer's DiseaseImmunologyDegenerative PathologyProtein Misfolding	1999	3.1K
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein Dora Games, David S. Adams, Ree Alessandrini, Nature Alzheimer-type NeuropathologyNeurodegenerative DiseasesAlzheimer's DiseaseMolecular NeuroscienceTransgenic Mouse Models	1995	2.5K
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Frédérique Bard, Catherine Cannon, Robin Barbour, Nature Medicine Amyloid β-Peptide EnterNeurodegenerative DiseasesAlzheimer's DiseaseMedicineImmunology	2000	2K
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease Teresa Gómez‐Isla, Joseph L. Price, Daniel W. McKeel, Journal of Neuroscience	1996	1.8K
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline Jan Näslund JAMA	2000	1.3K
In vivo dendritic calcium dynamics in neocortical pyramidal neurons Karel Svoboda, Winfried Denk, David Kleinfeld, Nature Synaptic PlasticityCellular NeurobiologyDendritic SpinesNeurodynamicsNeurophysiology	1997	825
Alzheimer Neuropathologic Alterations in Aged Cognitively Normal Subjects D. G. Davis, Frederick A. Schmitt, David R. Wekstein, Journal of Neuropathology & Experimental Neurology	1999	518
Aβ Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic Mouse Michael C. Irizarry, Ferdie Soriano, M. McNamara, Journal of Neuroscience	1997	499
Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide. Beka Solomon, Reine Koppel, Tamar Katzav Proceedings of the National Academy of Sciences ImmunologyPeptide ScienceImmunotherapyAlzheimer's DiseaseDegenerative Pathology	1996	312

Page 1